July 2020 Preferred Drug List
- Preferred Drug List and Prior Authorization Criteria (PDF)
- Published July 27, effective July 30; updated Sept. 17
Preferred drugs are medications recommended by the Texas Drug Utilization Review Board for their efficaciousness, clinical significance, cost effectiveness, and safety. The Texas Medicaid Formulary contains all formulary products, including those on the preferred drug list, available to people enrolled in Medicaid. Preferred products are available without prior authorization, although they may be subject to clinical prior authorization. Drugs identified as non-preferred on the PDL require a prior authorization. Medicaid managed care plans are required to follow the PDL. The preferred drug list is published every January and July, and is also available through Epocrates.
Obtaining Prior Authorization
Prescribing providers or their representatives should contact one of the following authorization authorities to obtain non-preferred prior authorization:
Medicaid Managed Care
- Refer to the Prescriber MCO Assistance Chart (PDF) for each MCO's prior authorization and member call center telephone numbers. The MCO must notify the prescribing provider of authorization approval or denial within 24 hours of the time of the request.
- The Texas Prior Authorization Call Center accepts prior authorization requests by phone at 1-877-PA-TEXAS (1-877-728-3927) or online through PAXpress.
|Preferred Drug List and Prior Authorization Criteria (PDF)||Jan. 30, 2020|
|Preferred Drug List and Prior Authorization Criteria (PDF)||July 25, 2019|
October 1, 2020
Testimony Instruction for the Oct. DUR Board Meetings
September 30, 2020
Registration Information for the Oct. DUR Board Meeting
September 21, 2020
July 2020 Preferred Drug List Revised Sept. 17
September 18, 2020
Branded Concerta Tablets Return to Non-Preferred Status on Oct. 16
September 14, 2020
Two-day DUR Board Meeting Scheduled for Oct. 22 and 23
September 9, 2020
Insulin Products Return to Non-Preferred Status on Sept. 18